{"transactions":[{"id":1612524,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T18:14:56.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":2917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on February 26, 2025, one year following the grant date."}],"balance_after":2917,"derivative":{"exercise_price":0.357,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":2917},"source":{"system":"sec-edgar","filing":"0001415889-24-005686","document":"form4-02282024_060247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588924005686/form4-02282024_060247.xml","form_type":"4"}},{"id":1799764,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-22T19:57:39.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":15335,"price":1.3037,"value":19992.2395,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.26 to $1.36, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":52045,"source":{"system":"sec-edgar","filing":"0001415889-23-012474","document":"form4-08222023_070830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923012474/form4-08222023_070830.xml","form_type":"4"}},{"id":1849748,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T17:53:39.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 14, 2024, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":1.85,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-23-009983","document":"form4-06202023_050635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588923009983/form4-06202023_050635.xml","form_type":"4"}},{"id":2218779,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T18:08:11.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on June 23, 2023, one year following the grant date."}],"balance_after":5250,"derivative":{"exercise_price":4.23,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001415889-22-007094","document":"form4-06302022_110603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922007094/form4-06302022_110603.xml","form_type":"4"}},{"id":2263949,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T15:44:58.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":241,"price":4.5,"value":1084.5,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":36710,"source":{"system":"sec-edgar","filing":"0001415889-22-005272","document":"form4-05192022_080545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922005272/form4-05192022_080545.xml","form_type":"4"}},{"id":2265921,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T15:24:25.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":13450,"price":4.3802,"value":58913.69,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.94 to $4.57, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":36469,"source":{"system":"sec-edgar","filing":"0001415889-22-005214","document":"form4-05182022_080517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922005214/form4-05182022_080517.xml","form_type":"4"}},{"id":2314291,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-30T15:55:24.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":600,"price":4.9408,"value":2964.48,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.94 to $4.97, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":23019,"source":{"system":"sec-edgar","filing":"0001415889-22-003465","document":"form4-03302022_080315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922003465/form4-03302022_080315.xml","form_type":"4"}},{"id":2318967,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T18:52:33.000Z","date":"2022-03-23","kind":"purchase","acquired":true,"shares":2197,"price":5.4627,"value":12001.5519,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.37 to $5.48, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects corrected holdings, as prior reports incorrectly understated indirect holdings and overstated direct holdings, by 1,500 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":22419,"source":{"system":"sec-edgar","filing":"0001415889-22-003314","document":"form4-03242022_110324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922003314/form4-03242022_110324.xml","form_type":"4"}},{"id":2422698,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-28T20:30:24.000Z","date":"2022-01-27","kind":"purchase","acquired":true,"shares":4180,"price":5.9803,"value":24997.654,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.80 to $6.27, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":18722,"source":{"system":"sec-edgar","filing":"0001415889-22-000846","document":"form4-01282022_120112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922000846/form4-01282022_120112.xml","form_type":"4"}},{"id":2449897,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T20:23:08.000Z","date":"2022-01-03","kind":"purchase","acquired":true,"shares":2215,"price":5.4329,"value":12033.8735,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.20 to $5.70, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":14542,"source":{"system":"sec-edgar","filing":"0001415889-22-000167","document":"form4-01042022_120157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922000167/form4-01042022_120157.xml","form_type":"4"}},{"id":2461265,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T18:28:40.000Z","date":"2021-12-21","kind":"purchase","acquired":true,"shares":8827,"price":5.6641,"value":49997.0107,"ownership":{"direct":false,"nature":"401 (k) Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.375 to $5.8799, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. (\"Virios\"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":12327,"source":{"system":"sec-edgar","filing":"0001415889-21-006174","document":"form4-12222021_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921006174/form4-12222021_101232.xml","form_type":"4"}},{"id":2637130,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-09T17:36:49.000Z","date":"2021-07-07","kind":"purchase","acquired":true,"shares":942,"price":6.317,"value":5950.614,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include 18,201 shares that were previously reported on the reporting person's Form 3 and prior Forms 4.  Such shares were included in the person's holdings in error."}],"balance_after":710734,"source":{"system":"sec-edgar","filing":"0001415889-21-003569","document":"form4-07092021_100738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921003569/form4-07092021_100738.xml","form_type":"4"}},{"id":2657562,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T19:26:05.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 equal monthly installments following the grant date."}],"balance_after":7875,"derivative":{"exercise_price":6.5,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001415889-21-003158","document":"form4-06232021_120654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588921003158/form4-06232021_120654.xml","form_type":"4"}},{"id":2888888,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-02-02T00:54:25.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":7.8,"exercise_date":"2020-12-16","expiration_date":"2021-01-20","underlying":"Common Stock","underlying_shares":801},"source":{"system":"sec-edgar","filing":"0001104659-21-010386","document":"tm214953-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921010386/tm214953-2_4seq1.xml","form_type":"4"}},{"id":2888887,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T00:54:25.000Z","date":"2021-01-29","kind":"purchase","acquired":true,"shares":3500,"price":7.47,"value":26145.0,"ownership":{"direct":false,"nature":"401(k) Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee."}],"balance_after":3500,"source":{"system":"sec-edgar","filing":"0001104659-21-010386","document":"tm214953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921010386/tm214953-2_4seq1.xml","form_type":"4"}},{"id":2888886,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T00:54:25.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":801,"price":7.8,"value":6247.8,"ownership":{"direct":true},"balance_after":727993,"source":{"system":"sec-edgar","filing":"0001104659-21-010386","document":"tm214953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921010386/tm214953-2_4seq1.xml","form_type":"4"}},{"id":2936392,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":93756,"kind":"person","name":"Pridgen William","position":1,"cik":"0001826115","reported_name":"Pridgen William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T01:10:42.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1500,"price":11.98,"value":17970.0,"ownership":{"direct":true},"balance_after":727192,"source":{"system":"sec-edgar","filing":"0001104659-20-138199","document":"tm2039099-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465920138199/tm2039099-1_4.xml","form_type":"4"}}]}